The National Institute of Neurology and Neurovascular Diseases in Romania is seeking suppliers for the procurement of systemic antibiotics. This contract involves the acquisition of antibiotics that meet the technical specifications outlined in the awarding documentation. The total value of the cont
Contract awarded. Originally published 1 years ago.
No single supplier dominates the field.
In healthcare medical, NATIONAL INSTITUTE OF NEUROLOGY AND NEUROVASCULAR DISEASES has awarded 3 contracts to 2 suppliers.
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
The National Institute of Neurology and Neurovascular Diseases in Romania is seeking suppliers for the procurement of various medicines. This contract involves the purchase of diverse medications according to the technical specifications outlined in the award documentation. The total value of the co
The National Institute of Neurology and Neurovascular Diseases in Romania is seeking suppliers for the procurement of various medicines. This contract involves the purchase of diverse medications according to the technical specifications outlined in the award documentation. The total value of the co
The National Institute of Neurology and Neurovascular Diseases in Romania is seeking suppliers for the procurement of infusion solutions. This contract involves acquiring infusion solutions that meet the technical specifications outlined in the tender documentation. Suppliers interested in this oppo
Ireland is seeking a qualified occupational health services provider to deliver comprehensive workplace health assessments, medical surveillance, and occupational health advisory services.
NHSBT seeks suppliers of colour-coded EDTA sample tubes with bar-code labels to support testing of 1.5 million annual blood and tissue donations across two English facilities.
BHRUT seeks an outsourced dermatology service provider to treat 800 waiting list patients from November 2026 to March 2027 (£520,000 contract value).
A competitive NHS framework agreement enabling the supply of unlicensed imported medicines to healthcare organisations and eligible public bodies, subject to strict regulatory compliance and quality assurance standards.
